Member directory

Reneuron

ReNeuron is a leading, clinical-stage cell therapy development company. Based in the UK, ReNeuron has therapeutic candidates in clinical development for motor disability as a result of stroke, for critical limb ischaemia and for the blindness-causing disease, retinitis pigmentosa. ReNeuron is also advancing its proprietary exosome technology platform as a potential new nanomedicine targeting cancer and as a potential delivery system for gene therapy treatments.

Website

www.reneuron.com

Email

info@reneuron.com

Telephone

020 3819 8400

Address

Pencoed Business Park
Pencoed
Bridgend

CF35 5HY

Reneuron news articles

13 July 2018

ReNeuron strikes US exclusivity deal


Read more

8 November 2017

Development of Exosomes for Cancer Treatment Accelerates in Wales


Read more

31 October 2017

ReNeuron awarded additional grant funding


Read more